Opportunities from CATS.
Seminar: Developing a new drug - the pathway towards successful translation
Professor Peter Weissberg, Advisor for life-sciences investments, Medicxi
Large Seminar Room, First floor, Institute of Public Health, Cambridge Biomedical Campus, CB2 0SR
This seminar by Prof. Peter Weissberg will cover key criteria for research translatability that should guide development of a new therapeutics strategy as well as achieve a commercial proposition for attracting investments. These criteria include consideration of product differentiation, target validation, risk reduction and proof-of-concept clinical trial design. To illustrate these points, Peter will refer to case-studies such as X01 Ltd., a Cambridge based company. The seminar will also provide an opportunity to discuss particular issues relating to your own research with the speaker.
Prof. Peter Weissberg is currently an investment advisor for Medicxi, a leading life sciences-focused venture capital firm, having recently stepped down from his role as Medical Director of the British Heart Foundation. Prior to that he was the BHF Professor of Cardiovascular Medicine in the University of Cambridge and Consultant Cardiologist at Addenbrooke’s Hospital. He is a fellow of Wolfson College Cambridge, the Academy of Medical Sciences and the Royal College of Physicians and currently chairs UK Bio Centre and the Research Council of the Scar Free Foundation. In 2017, he was appointed CBE for services to medical research and cardiovascular health.
This event is open to all but you must register if you plan to attend:
Cambridge New Therapeutics Forum (CamNTF)
Tuesday 25th September,, including networking drinks reception
Milstein Building, Granta Park, Cambridge, CB21 6GH
The September meeting of the Cambridge New Therapeutics Forum (CamNTF) is hosted by AstraZeneca. This scientific forum is open to all scientists at any level interested in research and development of therapeutics in Cambridge and the local area, including researchers at the University, hospitals, and industry. The aim is to promote interactions between these organisations to improve opportunities for biotechnology R&D. Hear from Professor Slave Petrovski, about his work on genomic analysis of common disease, as well as talks from two of the AZ genomics post-doctoral fellows.
Attendance is free and open to all. For more information and to register, please visit:
Healthy Ageing Industrial Strategy Challenge Fund Industry Workshop
Tuesday 11th September, London
Innovate UK, ESRC and KTN are hosting an industry workshop to explain more about the Healthy Ageing Industrial Strategy Challenge Fund (ISCF) competitions and to gather ideas and feedback on the potential level of interest from industry. As part of the Healthy Ageing ISCF the government will invest up to £98m to create new consumer products and services underpinned by technology. Research and innovation commissioned through the Healthy Ageing challenge will support people in the UK to remain healthy, active, productive, independent and connected to their communities into old age. For more information:
MRC Integrative Toxicology Training Partnership studentships – applications invited from potential academic supervisors
MRC ITTP 4-year studentships are available starting October 2019, funded by the MRC Toxicology Unit, to build expertise in toxicology and related disciplines to ensure the safe development of drugs, chemicals and consumer products, and assessment of risk from environmental exposure. Projects should achieve cross-fertilisation between toxicology and other disciplines to predict the toxicity of chemicals and drugs as well as to develop an understanding of the chemical, pharmacological and biological processes involved.
Applications must be submitted from potential academic supervisors with partners in industry, government agencies or other universities. All applicants are first required to attend an interactive meeting at the MRC Toxicology Unit in Leicester on http://www.mrc-tox.cam.ac.uk/ittp/to discuss ideas. If the lead applicant is unavailable, a senior collaboration representative can attend. For more information and details on how to register for the event, please visit:
Milner Therapeutics Symposium 2018
Monday 1st October
West Road Concert Hall, Cambridge
Abstract submission deadline 14th September
Registration to The Milner Therapeutics Symposium 2018 is now open. Registration to the symposium is free, book now to secure your space. CLICK HERE TO REGISTER. This Symposium is an opportunity for scientists from academia and industry to discuss the latest academic and clinical research and how it could be applied in the pharma and biotech industry to develop new treatments. It is our key networking event for Milner Therapeutics Institute alliance partners.
Abstract submissions: Academic poster presentations are available at the Symposium. Please register via the Eventbrite page and submit an abstract of no more than 250 words to firstname.lastname@example.org. The abstract submission deadline is .
8th Annual Biologics Symposium
1-2nd October 2018
IET London: Savoy Place
This two day educational event brings together peers from across the biologics community to share information and discuss real life research, techniques and challenges in biological drug development. The event has been CPD accredited. For details or to register, please visit: https://www.eventbrite.co.uk/e/8th-annual-biologics-symposium-london-tickets-36304543868. Tickets are on sale for £99 for a two-day pass, however there is a 50% discount available via CATS using the promotional code: CATS18 which you should enter when registering on the Eventbrite site.
Advances at the interface between metabolism and epigenetics conference
16th-17th January 2019
Robinson College Cambridge
£160 or £130 excluding conference dinner, discounted rate for students.
The Cambridge Metabolic Network invites you to join them in Cambridge onfor their conference: . Registration is open now for this 2 day meeting which will bring together international experts and newcomers to the fields of metabolism and epigenetics, including cancer researchers, biochemists, clinicians, geneticists, computational/ informatics researchers and others with an interest in epigenetics. #EpiMet19
Please pass on these opportunities to other colleagues who may be interested or encourage them to sign up to our mailings. If you no longer wish to receive these emails then please just let us know.
We look forward to seeing you soon.
With best wishes,
Posted on 24/08/2018
Go to the news index page.